All DPP-4 inhibitors are orally active, specific for DPP-4 and with a high affinity to the enzyme, although their binding characteristics and pharmacokinetic properties differ ( Table 1 Structure, clinical dose (reflecting potency), and dates of approval by United States Food and Drug Administration (FDA) and European Medicines Agency (EMA) for the DPP-4 inhibitors, sitagliptin, vildagliptin, saxagliptin, alogliptin, and linagliptin, which were the first DPP-4 inhibitors reaching the market
Report any unusual symptoms to your doctor, including persistent muscle pain, joint pain, skin changes, or new digestive symptoms
Glutathione reduces oxidative stress that may be the cause of thyroid dysfunction
Always use bacteriostatic water (which contains 0.9% benzyl alcohol as a preservative), never sterile water, for multi-dose vials
In todays environment, your skin is constantly exposed to stressors such as pollution, UV rays, and lifestyle factors that contribute to premature aging and dullness
Full body tracking ensures safety in study protocols